ArticleCurrent neuropharmacology2026
Research Hotspots and Frontiers of Ischemic Stroke and Traditional Chinese Medicine: A Knowledge Mapping and Text Mining Analysis.
Article in Current neuropharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Molecular Mechanisms and Clinical Applications of Buyang Huanwu Decoction in the Treatment of Ischemic Stroke: A Review.International journal of general medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectiveIschemic stroke is a complex neurological disease with poor prognosis, resulting in significant economic burdens for patients, their families, and society at large. Traditional Chinese Medicine (TCM) offers unique advantages and has been utilized for thousands of years in the prevention and treatment of ischemic stroke. However, there is currently a lack of bibliometric analysis and knowledge mapping regarding TCM treatments for this condition. To identify the key areas and future directions of TCM treatment for Ischemic Stroke.
methodsWe extracted articles on TCM treatments for ischemic stroke from the Web of Science Core Collection (WoSCC) database, spanning from January 1, 1990, to March 20, 2025, and conducted a bibliometric analysis. Data processing was performed using CiteSpace, VOSviewer, and Origin2024b.
resultsWe collected 506 published papers, with China accounting for the majority of these publications (97.0 %, 418 articles). The Journal of Ethnopharmacology and Frontiers in Pharmacology were the two most frequently published journals. The leading institutions contributing to this research included the Chinese Academy of Medical Sciences, Beijing University of Chinese Medicine, and Peking Union Medical College (now known as Capital Medical University). The primary research hotspots in TCM treatment for ischemic stroke focused on protective effects, brain injury, and neural regeneration. Notably, network pharmacology, molecular docking, and metabolomics were identified as the commonly used research methods. Among them, network pharmacology was the most frequently used research method. Additionally, we summarized the TCM remedies that have been extensively researched and cited in the context of ischemic stroke, including catalpol, angong niuhuang wan, buyang huanwu decoction, jeo-dang-tang, yiqifumai powder injection, and gualou guizhi decoction.
conclusionThe work highlights the key topics and recent research frontiers, providing valuable resources for scholars interested in the role of TCM in treating ischemic stroke.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.